Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 0192

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.17, p 0.663). This receipt's hash covers every field on it, plus the hash of receipt 191, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 0192
    16 Oct 2026, 18:42 UTC

    CDKN1C

    dopamine neurons, braak

    predictionCDKN1C in dopamine neurons tracks Braak Lewy-body stage

    registered88099861312ae169

    discovery-0.17 p=0.663 n=9

    replication+0.30 p=0.428 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.17, p 0.663)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    d8a1e97e22b836f2e45629c8…
    follows 36b21c72ae35…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 0192: CDKN1C in dopamine neurons, braak

power
full sample +0.10 (p 0.690, n 18), 95% CI -0.38 to +0.54. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.09 (p 0.735, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.14 (p 0.579, n 18). could be the mix.
skeptic
leave-one-out range -0.02 to +0.24, sign flips 1; without severely affected donors +0.10 (p 0.690, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CDKN1C in dopamine neurons.

case closed: nothing better to follow up.